Franklin Resources

Franklin Resources’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Franklin Resources’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-289,400	Closed	-$1.14M	–	1544
2017 Q1	$1.14M	Sell	289,400 -50,000	-15%	-$251K	﹤0.01%	1308
2016 Q4	$1.66M	Hold	339,400	–	–	﹤0.01%	1262
2016 Q3	$2.63M	Hold	339,400	–	–	﹤0.01%	1213
2016 Q2	$1.9M	Hold	339,400	–	–	﹤0.01%	1255
2016 Q1	$1.83M	Hold	339,400	–	–	﹤0.01%	1264
2015 Q4	$2.96M	Hold	339,400	–	–	﹤0.01%	1231
2015 Q3	$2.85M	Hold	339,400	–	–	﹤0.01%	1236
2015 Q2	$5.98M	Buy	+339,400	New	+$4.36M	﹤0.01%	1146

Other funds holding SRNE

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return